US Edition3D Printing Could Enable a Long-Term Treatment for Type 1 Diabetes
- In 2023, a clinical trial showed that a single infusion of zimislecel, pancreatic cells from donors, allowed 10 of 12 adults with type 1 diabetes to stop insulin injections for a year.
- This trial arose because type 1 diabetes destroys insulin-producing cells and earlier treatments depended on scarce donor organs for islet or pancreas transplants.
- Participants also avoided severe hypoglycemia during the year, but the trial had no control group, was small, and required immunosuppression, which carries infection risks.
- Diabetes researcher Giacomo Lanzoni described the study as groundbreaking, and the team plans to seek official authorization to use the treatment by 2026.
- These results represent a major step toward long-term treatment that could reduce reliance on insulin injections and donor organs but need confirmation by further research.
13 Articles
13 Articles
Le Charlevoisien
A stem cell therapy re-established insulin production in about ten patients with type 1 diabetes reveals a study published by the prestigious New England Journal of Medicine. This study, while far from perfect, brings us a little closer to the day when these patients will no longer need insulin doses to control their blood sugar levels, commented Dr. Rémi Rabasa-Lhoret, an expert in this disease at the Montreal Clinical Research Institute who ha…
Small 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to produce their own insulin People with type 1 diabetes cannot produce enough insulin to regulate their blood sugar levels Researchers have 3D-printed devices [...]
3D Printing Pioneers Safer, Long-Term Treatments for Type 1 Diabetes
Individuals with type 1 diabetes struggle to produce sufficient insulin for blood sugar regulation Half Point Image/Getty Image Researchers have developed a 3D-printed device comprising insulin-producing cells, offering potential for long-term management of type 1 diabetes by enabling patients to generate their own insulin without invasive surgery. Type 1 diabetes patients typically lack the ability [...] The post 3D Printing Pioneers Safer, Lon…
3D printing could enable a safer long-term therapy for type 1 diabetes
People with type 1 diabetes can’t produce enough insulin to regulate their blood sugar Halfpoint Images/Getty Images Researchers have 3D printed devices made of insulin-producing cells. These devices could enable a long-term treatment for type 1 diabetes that would let people produce their own insulin – without requiring invasive surgery. Because people with type 1 […] The post 3D printing could enable a safer long-term therapy for type 1 diabet…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
